Mega Lifesciences Public Co. Ltd. (MEGA) Stock Statistics & Valuation Metrics

Mega Lifesciences Public Co. Ltd. has a market cap or net worth of THB 30.73B. The enterprise value is THB 28.71B.

Market Cap

THB 30.73B

Enterprise Value

THB 28.71B

Mega Lifesciences Public Co. Ltd. has 871,869,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

871,869,500

Owned by Insiders

―

Owned by Institutions

―

Mega Lifesciences Public Co. Ltd.’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 20.18%.

Return on Equity (ROE)

0.19

Return on Assets (ROA)

0.12

Return on Invested Capital (ROIC)

20.18%

Return on Capital Employed (ROCE)

0.27

Revenue Per Employee

15.72M

Profits Per Employee

2.12M

Employee Count

900

Asset Turnover

0.88

Inventory Turnover

2.19

The current PE Ratio of Mega Lifesciences Public Co. Ltd. is 14.04. Mega Lifesciences Public Co. Ltd.’s PEG ratio is 0.81.

PE Ratio

14.04

PS Ratio

2.12

PB Ratio

2.97

Price to FCF

13.70

Price to Operating Cash Flow

11.00

PEG Ratio

0.81

In the last 12 months, Mega Lifesciences Public Co. Ltd. had revenue of 14.15B and earned 1.91B in profits. Earnings per share was 2.19.

Revenue

14.15B

Gross Profit

7.27B

Operating Income

2.90B

Pretax Income

2.40B

Net Income

1.91B

EBITDA

2.74B

Earnings Per Share (EPS)

2.19

In the last 12 months, operating cash flow was 2.79B and capital expenditures -548.60M, giving a free cash flow of 2.24B billion.

Operating Cash Flow

2.79B

Free Cash Flow

2.24B

Free Cash Flow per Share

2.57

Mega Lifesciences Public Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of 4.68%

Dividend Per Share

―

Dividend Yield

4.68%

Payout Ratio

N/A

Free Cash Flow Yield

7.30%

Earnings Yield

7.13%

Beta

0.61

52-Week Price Change

20.51%

50-Day Moving Average

―

200-Day Moving Average

―

Relative Strength Index (RSI)

57.61

Average Volume (3m)

1.02M

Mega Lifesciences Public Co. Ltd. upcoming earnings date is Nov 16, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 13, 2026

Next Earnings Date

Nov 16, 2026

Ex-Dividend Date

―

Mega Lifesciences Public Co. Ltd. as a current ratio of 2.23, with Debt / Equity ratio of 6.69%

Current Ratio

2.23

Quick Ratio

1.61

Debt to Market Cap

0.02

Net Debt to EBITDA

-1.31

Interest Coverage Ratio

52.70

In the past 12 months, Mega Lifesciences Public Co. Ltd. has paid 492.21M in taxes.

Income Tax

492.21M

Effective Tax Rate

0.20

Mega Lifesciences Public Co. Ltd. EV to EBITDA ratio is 9.01, with an EV/FCF ratio of 12.37.

EV to Sales

1.92

EV to EBITDA

9.01

EV to Free Cash Flow

12.37

EV to Operating Cash Flow

9.94

Mega Lifesciences Public Co. Ltd. has THB 4.02B in cash and marketable securities with THB 694.75M in debt, giving a net cash position of THB 3.33B billion.

Cash & Marketable Securities

THB 4.02B

Total Debt

THB 694.75M

Net Cash

THB 3.33B

Net Cash Per Share

THB 3.82

Tangible Book Value Per Share

THB 10.35

Gross margin is 52.43%, with operating margin of 20.92%, and net profit margin of 15.12%.

Gross Margin

52.43%

Operating Margin

20.92%

Pretax Margin

19.38%

Net Profit Margin

15.12%

EBITDA Margin

21.27%

EBIT Margin

19.36%

The average price target for Mega Lifesciences Public Co. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

1.53%

EPS Growth Forecast

17.58%